Allogenica
Pre-clinicalWe are committed to making T-cell therapies universally accessible by delivering treatments that are safer, more readily available to patients, and up to ten times less expensive to manufacture.
Founded
2019
Focus
Cell & Gene Therapy
About
We are committed to making T-cell therapies universally accessible by delivering treatments that are safer, more readily available to patients, and up to ten times less expensive to manufacture.
Funding History
1Total raised: $4.5M
Seed$4.5MUndisclosedMay 15, 2020
Company Info
TypePrivate
Founded2019
LocationParis, France
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile